Skip to main content

Table 2 Comparison between the two studied groups according to HCC treatment

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

HCC treatment modalitiesGroup I (n = 50), no. (%)Group II (n = 50), no. (%)χ2p
Hepatic resection11 (22%)12 (24%)1.0020.182
RFA27 (54%)35 (70%)3.5490.420
LDLT10 (20%)0 (0.0%)7.696*p = 0.006*
Alcohol injection2 (4.0%)3 (6.0%)1.010p = 1.000
  1. RFA radiofrequency ablation, LDLT living donor liver transplant
  2. *Statistically significant at p ≤ 0.05